NewcelX NCEL
NASDAQ NCEL
$2.79 +0.03 (+1.05%)
As of: Oct 21, 2026 · 3:59 PM EDT

NewcelX (NCEL) Total Debt (2019 - 2026)

Updated

NewcelX's Total Debt came in at $392,000 for Q2 2026.

Analysis

NewcelX (NCEL) Total Debt (2019 - 2026) Analysis & Trends

At the end of FY2025, NewcelX's Total Debt was $355,000, down 69.2% from FY2024.

  • Total Debt carries a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
  • Going back by year, Total Debt was $1.15 million in FY2024 (-40.4%), $1.93 million in FY2023 (+59.3%), $1.21 million in FY2022 and -$277,537 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Total Debt since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 NewcelX 11.34 Mn 4.68 Mn - 392,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 392,000.00
Dec 31, 2025 355,000.00
Jun 30, 2025 1.12 Mn
Dec 31, 2024 3.53 Mn
Jun 30, 2024 1.71 Mn
Dec 31, 2023 3.27 Mn
Jun 30, 2023 318,000.00
Dec 31, 2022 292,000.00
Jun 30, 2022 354,336.00
Dec 31, 2021 -277,537.00
Jun 30, 2021 463,980.00
Dec 31, 2020 1.49 Mn
Dec 31, 2019 690,071.00
API Access

NewcelX Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NCEL&period=max&api_key=YOUR_API_KEY